Loading clinical trials...
Loading clinical trials...
Evaluation of Two Methods for the Echocardiographic Assessment of Intrapulmonary Vasodilatation in Patients With Liver Cirrhosis: Agitated Saline Versus Polygelatine
The purpose of the study is to evaluate agitated saline versus polygeline for detection of intrapulmonary vasodilatation in patients with cirrhosis.
Intrapulmonary vasodilatation is a frequent finding in patients with cirrhosis. Its diagnosis is established via contrast enhanced echocardiography. One used method is the contrast agent agitated saline and another frequently used method is the contrast agent polygeline. The purpose of this study is to compare these two echocardiographic contrast agents with respect to their ability to detect intrapulmonary vasodilatation.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Intensive Care Unit 13H1, Dep. of Internal Medicine IV, Medical University of Vienna
Vienna, Vienna, Austria
Start Date
June 1, 2006
Last Updated
September 17, 2007
100
ESTIMATED participants
echocardiography for intrapulmonary vasodilatation
PROCEDURE
Lead Sponsor
Medical University of Vienna
NCT06345508
NCT05597488
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05128890